Skip to main content
SpringerLink
Log in

Female Sexual Dysfunction

  • Chapter
  • First Online:
Sexual Medicine

  • 1087 Accesses

Abstract

Female sexual dysfunction (FSD) represents an enigmatic yet complex set of disorders in this millennia, wherein significant changes have been implemented in defining, categorizing and managing these conditions. FSD is best viewed through a biopsychosocial modelled approach that integrates the ever-changing scenarios that can affect a woman’s health [1]. This includes a woman’s psychological issues, interpersonal factors, her current health status and other sociocultural factors. Women’s sexuality is highly complex and the association between various factors like society, family, relationship and health is strictly non-linear in nature [2]. A problem in any one of these areas can ultimately result in a sexual dysfunction. The aim of this chapter is to briefly overview the female sexual interest/arousal disorder and orgasmic disorder and also outline the management of the same. Female pain disorders now reclassified as the genito-pelvic pain disorder have been comprehensively reviewed separately in the textbook.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 89.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 89.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Althof S, Leiblum S, Chevret-Meason M, et al. Psychological and interpersonal dimensions of sexual function or dysfunction. J Sex Med. 2005;26:793–800.

    Article  Google Scholar 

  2. Rosen RC, Barsky JL. Normal sexual response in women. Obstet Gynecol Clin N Am. 2006;33:515–26.

    Article  Google Scholar 

  3. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-5®). Arlington, VA: American Psychiatric Publishing; 2013.

    Book  Google Scholar 

  4. Sungur MZ, Gunduz A. A comparison of DSM-IV-TR and DSM-5 definitions for sexual dysfunctions: critiques and challenges. J Sex Med. 2014;11(2):364–73.

    Article  Google Scholar 

  5. Clayton AH, Hamilton DV. Female sexual dysfunction. Obstet Gynecol Clin. 2009;36(4):861–76.

    Article  Google Scholar 

  6. Giles KR, McCabe MP. Conceptualizing women’s sexual function: linear vs. circular models of sexual response. J Sex Med. 2009;6(10):2761–71.

    Article  Google Scholar 

  7. Masters WH, Masters VJ. Human sexual inadequacy. New York City, New York: Bantam Books; 1980.

    Google Scholar 

  8. Sarin S, Amsel RM, Binik YM. Disentangling desire and arousal: a classificatory conundrum. Arch Sex Behav. 2013;42:1079–100.

    Article  Google Scholar 

  9. Graham CA, Brotto LA, Zucker KJ. Response to Balon and Clayton (2014): female sexual interest/arousal disorder is a diagnosis more on firm ground than thin air. Arch Sex Behav. 2014;43:1231–4.

    Article  Google Scholar 

  10. Balon R, Clayton AH. Female sexual interest/arousal disorder: a diagnosis out of thin air. Arch Sex Behav. 2014;43:1227–9.

    Article  Google Scholar 

  11. Bachmann GA, Leiblum S, Grill J. Brief sexual inquiry in gynecologic practice. Obstet Gynecol. 1989;73(3 pt 1):425–7.

    CAS  PubMed  Google Scholar 

  12. Angst J. Sexual problems in healthy and depressed persons. Int Clin Psychopharmacol. 1998;13(suppl 6):S1–4.

    Article  Google Scholar 

  13. Read S, King M, Watson J. Sexual dysfunction in primary medical care: prevalence, characteristics and detection by the general practitioner. J Public Health Med. 1997;19:387–91.

    Article  CAS  Google Scholar 

  14. Michael RT. Sex in America: a definitive survey. Boston: Little, Brown; 1994. p. 111–31.

    Google Scholar 

  15. Flynn KE, Reese JB, Jeffery DD, et al. Patient experiences with communication about sex during and after treatment for cancer. Psychooncology. 2012;21:594–601.

    Article  Google Scholar 

  16. Shifren JL, Monz BU, Russo PA, et al. Sexual problems and distress in United States women: prevalence and correlates. Obstet Gynecol. 2008;112:970–8.

    Article  Google Scholar 

  17. Kontula O, Haavio-Mannila E. Sexual pleasures. Enhancement of sex life in Finland 1971–1992. Dartmouth (NH): Aldershot Publishing; 1995.

    Google Scholar 

  18. Rosen C, Brown J, Heiman S, Leiblum C, Meston R, Shabsigh D, Ferguson R, D'Agostino R. The female sexual function index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther. 2000;26(2):191–208.

    Article  CAS  Google Scholar 

  19. Quirk FH, Heiman JR, Rosen RC, Laan E, Smith MD, Boolell M. Development of a sexual function questionnaire for clinical trials of female sexual dysfunction. J Womens Health Gend Based Med. 2002;11(3):277–89.

    Article  Google Scholar 

  20. Flynn KE, Lin L, Cyranowski JM, et al. Development of the NIH PROMIS® sexual function and satisfaction measures in patients with cancer. J Sex Med. 2013;10:43–52.

    Article  Google Scholar 

  21. Phillips NA. Female sexual dysfunction: evaluation and treatment. Am Fam Physician. 2000;62(1):127–48.

    CAS  PubMed  Google Scholar 

  22. Meston C, Buss D. Why women have sex: sexual motivation from adventure to revenge—and everything in between. London: The Bodley Head; 2009.

    Google Scholar 

  23. Clayton AH, Juarez EM. Female sexual dysfunction. Psychiatr Clin. 2017;40(2):267–84.

    Google Scholar 

  24. Kingsberg SA, Althof S, Simon JA, Bradford A, Bitzer J, Carvalho J, Flynn KE, Nappi RE, Reese JB, Rezaee RL, Schover L. Female sexual dysfunction—medical and psychological treatments, committee 14. J Sex Med. 2017;14(12):1463–91.

    Article  Google Scholar 

  25. Graziottin A, Leiblum SR. Biological and psychosocial pathophysiology of female sexual dysfunction during the menopausal transition. J Sex Med. 2005;2(s3:133–45.

    Article  Google Scholar 

  26. Rowland DL, Kolba TN. Understanding orgasmic difficulty in women. J Sex Med. 2016;13(8):1246–54.

    Article  Google Scholar 

  27. Clark L. Is there a difference between a clitoral and a vaginal orgasm? J Sex Res. 1970;6(1):25–8.

    Article  Google Scholar 

  28. Barbach LG. Group treatment of preorgasmic women. J Sex Marital Ther. 1974;1:139–45.

    Article  CAS  Google Scholar 

  29. Wylie K, Levin R, Hallam-Jones R, et al. Sleep exacerbation of persistent sexual arousal syndrome in a postmenopausal woman. J Sex Med. 2006;3:296–302.

    Article  Google Scholar 

  30. Komisaruk BR, Whipple B, Crawford A, et al. Brain activation during vaginocervical self-stimulation and orgasm in women with complete spinal cord injury: fMRI evidence of mediation by the vagus nerves. Brain Res. 2004;1024:77–88.

    Article  CAS  Google Scholar 

  31. Bradford A. Inhibited sexual desire in women. In: Grossman L, Walfish R, editors. Translating psychological research into practice. New York: Springer; 2014. p. 515–8.

    Google Scholar 

  32. Nairne KD, Hemsley DR. The use of directed masturbation training in the treatment of primary anorgasmia. Br J Clin Psychol. 1983;22:283–94.

    Article  Google Scholar 

  33. Riley AJ, Riley EJ. A controlled study to evaluate directed masturbation in the management of primary orgasmic failure in women. Br J Psychiatry. 1978;133:404–9.

    Article  CAS  Google Scholar 

  34. American Psychiatric Association. Training in and dissemination of empirically-validated psychological treatments: report and recommendations. Clin Psychol. 1995;48:3–24.

    Google Scholar 

  35. Schick V, Herbenick D, Rosenberger JG, et al. Prevalence and characteristics of vibrator use among women who have sex with women. J Sex Med. 2011;8:3306–15.

    Article  Google Scholar 

  36. Melnik T, Hawton K, McGuire H. Interventions for vaginismus. Cochrane Database Syst Rev. 2012;12:CD001760.

    PubMed  Google Scholar 

  37. Davis SR, Worsley R, Miller KK, et al. Androgens and female sexual function and dysfunction- findings from the fourth international consultation of sexual medicine. J Sex Med. 2016;13(2):168–78.

    Article  Google Scholar 

  38. Bachmann GA, Komi JO. Ospemifene Study Group. Ospemifene effectively treats vulvovaginal atrophy in postmenopausal women: results from a pivotal phase 3 study. Menopause. 2010;17(3):480–6.

    PubMed  Google Scholar 

  39. Gao Z, Yang D, Yu L, et al. Efficacy and safety of flibanserin in women with hypoactive sexual desire disorder: a systematic review and meta-analysis. J Sex Med. 2015;12:2095–104.

    Article  CAS  Google Scholar 

  40. Berman JR, Berman LA, Toler SM, et al. Safety and efficacy of sildenafil citrate for the treatment of female sexual arousal disorder: a double-blind placebo controlled study. J Urol. 2003;170(6 Pt 1):2333–8.

    Article  CAS  Google Scholar 

  41. Basson R, McInnes R, Smith MD, et al. Efficacy and safety of sildenafil citrate in women with sexual dysfunction associated with female sexual arousal disorder. J Womens Health Gend Based Med. 2002;11(4):367–77.

    Article  Google Scholar 

  42. Caruso S, Intelisano G, Lupo L, et al. Premenopausal women affected by sexual arousal disorder treated with sildenafil: a double-blind, cross-over, placebo controlled study. BJOG. 2001;108(6):623–8.

    CAS  PubMed  Google Scholar 

  43. Ito TY, Polan ML, Whipple B, et al. The enhancement of female sexual function with ArginMax, a nutritional supplement, among women differing in menopausal status. J Sex Marital Ther. 2006;32(5):369–78.

    Article  Google Scholar 

  44. Magon N, Kalra S. The orgasmic history of oxytocin: love, lust and labor. Indian J Endocrinol Metab. 2011;15(Suppl 3):S156–61.

    Article  Google Scholar 

  45. Behnia B, Heinrichs M, Bergmann W, et al. Differential effects of intranasal oxytocin on sexual experiences and partner interactions in couples. Horm Behav. 2014;65:308–18.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Reproductive Medicine, The Metromale Clinic & Fertility Center, Chennai, India

    Manu Lakshmi

  2. The Metromale Clinic and Fertility Center, No 1, Crescent Park Street, T-Nagar, Chennai, India

    Shah Dupesh Khan

Authors
  1. Manu Lakshmi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shah Dupesh Khan
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. The Metromale Clinic and Fertility Center, Chennai, India

    Karthik Gunasekaran

  2. The Metromale Clinic and Fertility Center, Chennai, India

    Shah Dupesh Khan

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Lakshmi, M., Khan, S.D. (2019). Female Sexual Dysfunction. In: Gunasekaran, K., Khan, S. (eds) Sexual Medicine . Springer, Singapore. https://doi.org/10.1007/978-981-13-1226-7_6

Download citation

  • DOI: https://doi.org/10.1007/978-981-13-1226-7_6

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-13-1225-0

  • Online ISBN: 978-981-13-1226-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation